NASDAQ: SBRA - Sabra Health Care

Yield per half year: -6.64%
Dividend yield: +7.94%
Sector: Real Estate

Sabra Health Care

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
31.74 37.34 -14.98% 68.7 -53.8%
P/S 5.72 7.32 -21.82%
P/BV 1.47 0.7524 95.02%
P/FCF 8.92 51.73 -82.76%
Ev/Ebitda 13.87 23.9 -41.94%
Ev/S 8.14 13.06 -37.66%
Ev/FCF 18.43 111.21 -83.42%
E/P 0.0457 0.0276 65.88%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
10/10
58.67 56.46 3.92% 50.4 +16.4%
ROE 4.57 1.33 243.74%
ROA 2.37 2.83 -16.17%
ROIC -0.81 3.02 -126.82%
ROS 18.02 18.71 -3.69%
ROCE 8.86 -10.74 -182.48%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
2/10
4.27 9.54 -55.24% 7.37 -42.02%
Nеt Debt/Ebitda 4.13 8.36 -50.66%
Debt/Ratio 0.3324 0.6285 -47.11%
Debt/Equity 0.3554 5.38 -93.4%
Debt/Net Income 13.91 36.79 -62.19%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
7.22 1.92 276.27% 8.68 -16.86%
Number of years of dividend growth 0 6.5 -100%
DSI 0.8571 0.9464 -9.43%
Average dividend growth -3.82 4.22 -190.51%
Average percentage for 5 years 8.68 4.04 114.9%
Average percentage for payments 371.53 113.58 227.12%
Difference from average difference in sector 5.3

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
3/10
17.48 -31.69 -155.16%
Growth impulse Ebitda in 5 years -1.29 -53.76 -97.6%
Growth impulse Net Income in 5 years -8.45 -248.03 -96.59%
Growth impulse FCF in 5 years -12.5 113.49 -111.01%
Growth impulse EPS in 5 years -19.63 1538.32 -101.28%
IP Score
4.41/10

Similar companies

SBA

Equinix, Inc. (REIT)

eXp World Holdings, Inc.

Regency Centers

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription